| COVID-19 vaccine administration |
-
-
Number of total doses administered
Number of total doses administered per 100,000 persons
Number of persons who received at least one dose
Number of persons fully vaccinated
Change in number doses administered since last week (total doses, total doses per 100,000 persons, persons who received at least one dose, persons fully vaccinated)
Number of persons who received at least one dose and number persons fully vaccinated over time, by week
Number of doses administered by vaccine manufacturer and dose number, where applicable
Number of persons who received at least one dose and number persons fully vaccinated by demographics (i.e., sex, age group, race/ethnicity, VSD site, high-risk for COVID-19 disease status, and COVID-19 disease history status) and by week
|
|
| COVID-19 vaccine coverage |
-
-
Number and proportion of VSD population who received at least one dose
Number and proportion of VSD population fully vaccinated
Number and proportion of VSD population who received vaccine, by vaccine manufacturer and dose number
Number and proportion of VSD population who received dose 1 and number and proportion of VSD population who received dose 2, by vaccine manufacturer and demographics
Number and proportion of VSD population who received at least one dose and number and proportion of VSD population fully vaccinated by demographics and by week
|
|
| Descriptive summaries of outcomes following COVID-19 vaccination |
-
-
Number of pre-specified outcomes that occurred by outcome type, vaccine manufacturer and dose number
Number of pre-specified outcomes that occurred by outcome type, vaccine manufacturer and dose number, average days to onset/diagnosis, sex, pregnancy status, and history of COVID-19 disease status
Outcome-specific visualizations that show number of outcomes by vaccine manufacturer and dose number, demographics, pregnancy status, and days to outcome diagnosis
Number of pre-specified outcomes by days since onset and rate per one million person-days, by pre-specified outcome
|
|
| Statistical analyses of COVID-19 vaccine outcomes |
-
-
Cumulative incidence of pre-specified outcomes during pre-specified post-vaccination risk intervals
Rate ratios to estimate the ratio of outcome incidence in the risk interval to the outcome incidence in the comparison interval with 95% confidence intervals
Sequential analyses results of the one-sided null hypothesis that the vaccine does not increase risk of outcome during the risk interval
|
|
| COVID-19 disease hospitalization counts |
-
-
Number of total COVID-19 hospitalizations among VSD population over time, by month
Number of total COVID-19 hospitalizations among VSD population over time (by month), compared to total number of dose 1 and dose 2 COVID-19 vaccine doses administered over time (by month)
Number of total COVID-19 hospitalizations among VSD population over time (by month), by demographics
Number of total lab-positive COVID-19 hospitalizations among VSD population over time (by month), by demographics
Number and proportion of deceased lab-positive COVID-19 hospitalized persons by sex and age group (denominator = all lab-positive COVID-19 hospitalized persons)
|
|
| Descriptive summaries of simultaneous vaccine administration with COVID-19 vaccine (i.e., administration of a non-COVID-19 vaccine on same day as a COVID-19 vaccine) |
-
-
Number of persons who received simultaneous vaccines with any dose of COVID-19 vaccine compared to number persons who initiated COVID-19 vaccine
Number of persons who received simultaneous vaccinations with COVID-19 vaccine, by COVID-19 vaccine manufacturer, dose number, and demographics
Number of persons who received simultaneous vaccines, by simultaneous vaccine name
Number of persons who received simultaneous vaccines, by simultaneous vaccine name and by week
|
|
| Descriptive summaries of COVID-19 disease and COVID-19 vaccination during pregnancy |
COVID-19 Vaccine Coverage
Number of pregnant persons in VSD population who received at least one dose of COVID-19 vaccine prior to or during most recent pregnancy
Timing of COVID-19 vaccine receipt among pregnant persons
Number of COVID-19 vaccines received by pregnant persons, by vaccine manufacturer and dose number
Number of pregnant persons who initiated COVID-19 vaccination and number of pregnant persons fully vaccinated by age group and race/ethnicity
Cumulative proportion of COVID-19 vaccine uptake among pregnant persons by age group and race/ethnicity
COVID-19 Disease Hospitalization
Number and proportion of pregnant persons hospitalized (denominator = total number women hospitalized of childbearing age)
Number of pregnant persons hospitalized by race/ethnicity and VSD site
Minimum, median, and maximum: 1) woman’s age at COVID-19 diagnosis in years; 2) number hospitalizations during pregnancy; 3) duration of hospital stay in days; 4) time from COVID-19 diagnosis to delivery; 5) gestational age at time of delivery in weeks
Number and proportion of pregnancy outcomes among women with an outcome (i.e., live born delivery; spontaneous abortion; live born or stillborn delivery; stillborn; therapeutic abortion; ectopic pregnancy)
Number babies born preterm |
